287 related articles for article (PubMed ID: 33081658)
1. Role of Nuclear Imaging in Cardiac Amyloidosis Management: Clinical Evidence and Review of Literature.
Frantellizzi V; Cosma L; Pani A; Pontico M; Conte M; De Angelis C; De Vincentis G
Curr Med Imaging; 2020; 16(8):957-966. PubMed ID: 33081658
[TBL] [Abstract][Full Text] [Related]
2. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.
Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS
Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
Pilebro B; Arvidsson S; Lindqvist P; Sundström T; Westermark P; Antoni G; Suhr O; Sörensen J
J Nucl Cardiol; 2018 Feb; 25(1):240-248. PubMed ID: 27645889
[TBL] [Abstract][Full Text] [Related]
4. The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis.
Morfino P; Aimo A; Giorgetti A; Genovesi D; Merlo M; Limongelli G; Castiglione V; Vergaro G; Emdin M
Heart Fail Clin; 2024 Jul; 20(3):307-316. PubMed ID: 38844301
[TBL] [Abstract][Full Text] [Related]
5. [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions.
Genovesi D; Vergaro G; Giorgetti A; Marzullo P; Scipioni M; Santarelli MF; Pucci A; Buda G; Volpi E; Emdin M
JACC Cardiovasc Imaging; 2021 Jan; 14(1):246-255. PubMed ID: 32771577
[TBL] [Abstract][Full Text] [Related]
6. Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis.
Ungericht M; Groaz V; Messner M; Schuetz T; Brunelli L; Zaruba MM; Lener D; Stocker E; Bauer A; Kroiss AS; Mayr A; Röcken C; Poelzl G
Amyloid; 2024 Mar; 31(1):22-31. PubMed ID: 37530216
[TBL] [Abstract][Full Text] [Related]
7. Radionuclide Imaging of Cardiac Amyloidosis.
Joseph V; Julien HM; Bravo PE
PET Clin; 2021 Apr; 16(2):285-293. PubMed ID: 33589384
[TBL] [Abstract][Full Text] [Related]
8. Advances in PET-Based Cardiac Amyloid Radiotracers.
Gallegos C; Miller EJ
Curr Cardiol Rep; 2020 May; 22(6):40. PubMed ID: 32430600
[TBL] [Abstract][Full Text] [Related]
9. Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects.
Clerc OF; Vijayakumar S; Dorbala S
Semin Nucl Med; 2024 Jul; ():. PubMed ID: 38960850
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.
Treglia G; Glaudemans AWJM; Bertagna F; Hazenberg BPC; Erba PA; Giubbini R; Ceriani L; Prior JO; Giovanella L; Slart RHJA
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1945-1955. PubMed ID: 29687207
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis.
Quarta CC; Zheng J; Hutt D; Grigore SF; Manwani R; Sachchithanantham S; Mahmood SA; Whelan CJ; Fontana M; Martinez-Naharro A; Chacko L; Lachmann HJ; Gillmore JD; Rapezzi C; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2021 Oct; 22(11):1304-1311. PubMed ID: 34254119
[TBL] [Abstract][Full Text] [Related]
13. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E
Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596
[TBL] [Abstract][Full Text] [Related]
14.
Morgenstern R; Yeh R; Castano A; Maurer MS; Bokhari S
J Nucl Cardiol; 2018 Oct; 25(5):1559-1567. PubMed ID: 28176254
[TBL] [Abstract][Full Text] [Related]
15. Emerging Role of Scintigraphy Using Bone-Seeking Tracers for Diagnosis of Cardiac Amyloidosis:
Slart RHJA; Chen W; Tubben A; Tingen HSA; Davies DR; Grogan M; Wechalekar AD; Kittleson MM; Thomson LEJ; Slomka PJ; Wechalekar K; Chareonthaitawee P
AJR Am J Roentgenol; 2024 Jan; 222(1):e2329347. PubMed ID: 37315017
[TBL] [Abstract][Full Text] [Related]
16. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
Fontana M; Ćorović A; Scully P; Moon JC
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
[TBL] [Abstract][Full Text] [Related]
17. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
Martini N; Rizzo S; Sarais C; Cipriani A
BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
[TBL] [Abstract][Full Text] [Related]
18. Multimodality assessments of wild-type transthyretin cardiac amyloidosis with no ventricular hypertrophy.
Iwaya T; Okada A; Tateishi E; Ohta Y; Morita Y; Ohta-Ogo K; Izumi C
ESC Heart Fail; 2023 Apr; 10(2):1412-1417. PubMed ID: 36335980
[TBL] [Abstract][Full Text] [Related]
19. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.
Gillmore JD; Maurer MS; Falk RH; Merlini G; Damy T; Dispenzieri A; Wechalekar AD; Berk JL; Quarta CC; Grogan M; Lachmann HJ; Bokhari S; Castano A; Dorbala S; Johnson GB; Glaudemans AW; Rezk T; Fontana M; Palladini G; Milani P; Guidalotti PL; Flatman K; Lane T; Vonberg FW; Whelan CJ; Moon JC; Ruberg FL; Miller EJ; Hutt DF; Hazenberg BP; Rapezzi C; Hawkins PN
Circulation; 2016 Jun; 133(24):2404-12. PubMed ID: 27143678
[TBL] [Abstract][Full Text] [Related]
20. Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.
Papantoniou V; Valsamaki P; Kastritis S; Tsiouris S; Delichas Z; Papantoniou Y; Tsiouma M; Athanasoulis T; Fotopoulos A; Dimopoulos MA
Hell J Nucl Med; 2015; 18 Suppl 1():42-50. PubMed ID: 26665211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
